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ABSTRACT
In this paper, we analyze the etiology of the diseases occurring during two consecutive influenza epidemic seasons in 
St. Petersburg, Russian Federation. The analysis is based on the results of the PCR diagnostics of the clinical samples 
collected from patients hospitalized in three St. Petersburg hospitals with influenza like illnesses (ILI). It was shown 
that the influenza virus A(H1N1)pdm09 was the dominant causative agent during the 2012-2013 epidemic season 
while, in the 2013-2014 season, A(H3N2) virus was predominant among adults and children. The influenza B virus 
activity was high in the 2012-2013 season and low in the 2013-2014 season. During both seasons, the main causative 
agent for the hospitalization of young children was respiratory syncytial virus (RSV), followed by rhinovirus and 
influenza virus. The rate of involvement of parainfluenza, adenovirus, metapneumovirus and coronavirus was low and 
was negligible for bocavirus. Children 0-2 and 3-6 years old formed the group of patients that was affected by acute 
respiratory infection agents the most. Children younger than 3 months old were the major group of the intensive care 
unit (ICUs) patients and only 27.5% of them were adults. RSV and rhinovirus were the leading cause of ILI among the 
children admitted to ICU. Among the adult patients admitted to the ICU, only influenza A(H1N1)pdm09, A(H3N2) and 
B viruses were detected during both influenza seasons.
According to the results of the antigenic and genetic analysis, most influenza A(H1N1)pdm09 and A(H3N2) viruses 
circulating in St. Petersburg matched the vaccine strains recommended by the WHO for vaccine composition in the 
2012-2013 and 2013-2014 seasons. 
INTRODUCTION
Hospital-based surveillance for the influenza like illnesses 
(ILI) and the severe acute respiratory illnesses (SARI) is 
an important part of multiplex influenza surveillance 
that is currently underdeveloped. Early recognition of a 
pandemic caused by a novel unidentified virus, through 
the investigation of ILI and SARI, is important to start the 
timely implementation of the Pandemic Preparedness 
Plan measures and rapid response of National Healthcare 
Service.
The last pandemic events were caused by the novel 
swine origin influenza A(H1N1)pdm09 virus that spread 
initially from Mexico to the United States and Canada 
and then globally starting from the spring - fall 2009 and 
finishing in mid-February 2010. Rates of hospitalization 
and death during this pandemic varied widely between 
countries [1]. The share of the hospitalized patients 
admitted to intensive care units (ICUs) varied from 9% to 
31% and the rate of death among them - from 14% to 46% 
[2-6]. Primary influenza pneumonia had a high mortality 
rate during pandemic among the immunocompromised 
individuals and the patients with underlying co-morbid 
conditions as well as among the young, healthy adults [7]. 
This study had several objectives: i. to analyze the 
clinical data for ILI related to influenza and other 
respiratory viruses among hospitalized patients (hILI) in 
the 2012-2013 and 2013-2014 seasons; ii. to investigate 
the dependencies between the patients’ age and the 
clinical characteristics of illnesses caused by influenza 
A(H1N1)pdm09, A(H3N2), and B viruses as detected by 
real-time reverse transcription (RT)-PCR analysis; iii. to 
compare these results with the conclusions from studies 
of diseases caused by other respiratory agents; iv. and 
finally to perform the antigenic and genetic analysis of 
the viruses isolated from hILI patients. 
MATERIALS AND METHODS
Standard operating procedures for on-site activities in 
a global influenza hospital-based surveillance network 
(GIHSN) were used across all the clinical investigations 
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[8, 9]. The surveillance group of healthcare professionals, 
trained to follow a common reference protocol, collected 
data on hospitalized patients with diagnoses potentially 
associated with influenza, according to European Influenza 
Surveillance Network (EISN) case definition [10].
The Local Research Ethics Committee of the Research 
Institute of Influenza approved the GISHN study. All 
information included in this study was collected from 
patients who provided written informed consent in 
accordance with Local Research Ethics Committee 
requirements personally or through their legal 
representatives.
Study population
Non-institutionalized patients hospitalized for at least 
24 h with a diagnosis possibly associated with influenza 
were considered eligible to be included in the study. 
Patients who were 5 or more years old had to meet the 
European Centre for Disease Prevention and Control’s 
clinical case definition of ILI [10] for at least one of four 
systemic symptoms (fever or feverishness, headache, 
myalgia, or malaise) and at least one of three respiratory 
symptoms (cough, sore throat or shortness of breathing). 
Children younger than 5 years old, as well as other 
patients, should be admitted to the hospital within 7 days 
of the appearance of the indicated above symptoms 
potentially associated with influenza. 
The study was conducted in three hospitals. Each of 
them had their own specific code: hospital code #1 with 
one ward for adults aged ≥ 17 years (60 beds); hospital 
code #2 with two wards for children aged from 0 to 
17 years (60 beds each); hospital code # 3 with two wards 
for children aged from 0 to 17 years (60 beds each). 
Hospitalization of patients with ILI was carried out 
according to the directions of physicians in different 
polyclinics or emergency services regardless of the 
patient residence area in St. Petersburg.
Data and sample collection 
The patient’s consent for participation in the study was 
obligatory. Nasopharyngeal swabs were taken from all of 
the patients. Additional pharyngeal swabs were collected 
from patients ≥14 years old and nasal samples were 
collected from younger patients. Samples were collected 
within 48 h of hospital admission and stored at −70°C 
before testing in the coordinating site’s laboratory. The 
patient’s status was recorded according to the answers to 
the core questionnaire that were given by the patient or 
his/her legal representative in the course of the face-to-
face interview with the attending physicians.
Confirmation of influenza infection
Real-time multiplex reverse transcription (RT)-PCR 
was performed according to the procedures described 
in the manufacturer’s instructions (InterLabService, 
Russia). RNA extraction and RT-PCR were performed at 
the coordinating site to detect the influenza A (H3N2), 
A(H1N1)pdm09, and B (Yamagata and Victoria 
lineages) viruses. The anonymized data from the core 
questionnaires were collected at the coordinating site 
and checked for missing, inconsistent, or incorrect data. 
Only the samples taken within 7 days of the onset of 
symptoms were included in the study. 
RT-PCR
RNA was isolated from 150-200 μl of sample resuspended 
in a virus transport medium using an AmpliSense® RIBO-
prep kit or QIAGEN RNeasy Mini kit. PCR for influenza 
A and B viruses was performed using AmpliSense® 
Influenza virus A/B-FL kit. Influenza A-positive samples 
were used for the subtyping of influenza viruses A(H1N1)
pdm09 and A(H3N2) using AmpliSense® Influenza virus 
A/H1–swine-FL and AmpliSense® Influenza virus A type 
FL kits. Reverse transcription of RNA was performed 
using Reverta-L kit (InterLabService, Russia) or QIAGEN 
OneStep RT-PCR Kit with primers and probes obtained 
from from the Centers for Disease Control and Prevention 
(CDC Atlanta, GA, USA). Determination of the lineage 
(Yamagata or Victoria) was performed for all influenza 
B virus positive specimens using QIAGEN OneStep RT-
PCR Kit with WHO recommended primers and probes. 
Detection of human respiratory syncytial virus (RSV), 
metapneumovirus, parainfluenza virus, coronavirus, 
rhinovirus, bocavirus was performed by analysis of cDNA 
obtained from specimens using AmpliSense® ARVI-
screen-FL kit (InterLabService, Russia). Adenovirus B, C, 
and E groups were also detected by using this system. All 
RT-PCR procedures were carried out on Rotor-Gene 6000, 
Corbett Research, Australia or CFX96 Touch™ Real-Time 
PCR Detection System, BIO-RAD, USA.
Virus isolation 
Virus isolation was performed in MDCK cell culture 
and 10-day-old chicken embryos (CE) incubated for 
72 hours at 34ºC according to the approved method [11]. 
Hemagglutination inhibition (HI) test was performed 
according to the standard method recommended by the 
WHO, with a 0.75% suspension of human red blood cells 
(group 0, Rh+) for the influenza A(H3N2) and B viruses. 
In the case of influenza A(H1N1)pdm09 isolates, a 0.5% 
suspension of chicken erythrocytes was used [12].
Sequencing 
Amplification of cDNA was performed by the standard 
method using original primers. Sequencing of influenza 
virus A genome fragments (genes HA, NA, M, and NS) was 
carried out on ABI PRISM 3100-Avant Genetic Analyzer 
(Applied Biosystems, USA) with BigDye Terminator Cycle 
Sequencing Kit v3.1.
Phylogenetic analysis
Processing and analysis of sequences was performed 
using the software Vector NTI v10.1.1 (Invitrogen) and 
MEGA 5 (PSU, USA). The method of maximum likelihood 
(ML) was used to build the phylogenetic trees. The choice 
of evolutionary models was performed according to the 
Akaike criterion (AIC) value using the ModelTest v3.7 
program. 
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Statistical analysis 
Statistical analysis and data management was performed 
using Statistica 10.0, including nonparametric statistic. 
Method Chi-square was used for the determination of 
significance in the differences of covariates.
RESULTS
Patients recruitment 
A total of 1,891 patients with acute respiratory symptoms 
hospitalized in the 5 wards of three hospitals of 
St. Petersburg during the periods of increased influenza 
activity (IAP) for the period from week 3 to week 22 in 
2013 and 1,713 patients hospitalized during IAP from 
week 4 to week 22 in 2014 were investigated. Among them 
192 and 422 patients, correspondingly, did not meet the 
study inclusion criteria and were excluded from further 
observation. As a result, 1,699 and 1,291 hospitalized 
ILI-patients were included in the investigation during 
IAP-2013 and IAP-2014, correspondingly, after obtaining 
informed consent and initial clinical analysis. Children 
younger than 17 years old formed the largest group of 
patients, namely 72.5% and 69.6% of the total number 
of patients in IAP-2013 and IAP-2014, correspondingly. 
Children younger than 1 year old and 1 to 4 years old 
dominated in the study. With the increase of the age, 
the frequency of children hospitalization decreased. The 
total number of adult patients was 27.5% and 30.4% in 
IAP-2013 and IAP-2014, respectively. The number of 
hospitalized elderly patients was very low during both 
years. No significant differences in the age distribution 
among the hospitalized patients were observed between 
IAP-2013 and IAP-2014 (Table 1).
Comparative data on the etiology of diseases among 
children and adults 
Investigation of clinical samples during the period of 
IAP in the 2012-2013 and 2013-2014 seasons revealed 
positive results for influenza and ARI agents in 52.4% 
and 58.2% of the investigated patients, respectively. 
Influenza cases were revealed in 34.7% of the patients in 
IAP-2013 and only in 15.1% in IAP-2014 when influenza 
activity in the city was low by both epidemiological 
and laboratory criteria. Influenza A(H1N1)pdm09 
and A(H3N2) diagnoses were confirmed significantly 
more often among adults from 18 to 84 years old than 
among children (Table 2). Influenza A(H1N1)pdm09 and 
influenza A(H3N2) viruses were causative agents of hILI 
in IAP-2013 while influenza A(H3N2) virus dominated 
in IAP-2014. Influenza B viruses (mainly the Yamagata 
lineage) caused hILI cases both in children and in adults 
in IAP-2013 but was very rarely detected in the patients 
in IAP-2014.
ARI agents, on the other hand, were detected more 
often in IAP-2014 than in IAP-2013 (40.8% and 12.7% 
of investigated patients, respectively), affecting mostly 
children. During both seasons, RSV was the most often 
causative agent of hILI among children, dominating 
among the other non-influenza respiratory agents 
(Fig. 1). In IAP-2013 this virus caused 13.5% of all hILI 
in children younger than 1 year old and 5.9% among 
the group of children 1 to 4 years old while in IAP-2014 
these numbers reached 40.2% and 22.8%, respectively. At 
the same time, RSV played a significant role in etiology 
of illnesses among the elderly patients. The second 
significant pathogen was rhinovirus, although its activity 
was several times lower than that of RSV during both IAPs. 
Rhinovirus, as well as RSV, more often affected children 
and elderly people. Parainfluenza and coronavirus were 
detected very rarely in IAP-2013 but somewhat more 
often in IAP-2014 (Table 2). Metapneumovirus and 
bocavirus were rarely observed as causative hILI agents 
in both seasons. 
Monitoring of the confirmed influenza cases 
First signs of influenza activity in St. Petersburg in 
2013 and 2014 were registered on week 3 and 4 of the 
Table 1. Distribution of the patients included in the St. Petersburg study by age groups.
Patients Age group (years) Number of patients investigated
2013 2014
Children Less than 1 year 533 (31.4 %) 368 (28.5%)
1-4 562 (33.1%) 416 (32.2%)
5-17 144 (8.5%) 115 (8.9%)
Subtotal children 1,239 (72.5%) 899 (69.6%)
Adults 18-49 310 (18.2%) 305 (23.6%)
50-64 113 (6.7%) 53 (4.1%)
65-74 18 (1.1%) 11 (0.9%)
75-84 17(1.0%) 22 (1.7%)
85 and older 2 (0.1%) 1 (0.1%)
Subtotal adults 467 (27.5%) 392 (30.4%)
Total patients 1,699 (100%) 1,291 (100%)
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Up to 1 533 8,1 4,5 6,9 0,6 1,3 1,7 13,5 0,8 1,3 42,8
1 - 4 562 10,1 8,7 8,4 0,9 1,4 2,5 5,9 0,4 4,4 48,2
5 - 17 144 9,0 5,6 25,7 1,4 1,4 2,1 2,1 1,4 4,2 58,3
18 - 49 310 24,5 10,6 17,1 4,5 0,3 0,0 1,3 0,0 2,3 65,8
50 - 64 113 23,9 13,3 23,0 0,0 0,0 1,8 0,0 0,0 0,0 70,8
65 - 74 18 16,7 27,8 11,1 5,6 0,0 0,0 0,0 0,0 0,0 61,1
75 - 84 17 23,5 11,8 17,6 0,0 0,0 0,0 5,9 0,0 0,0 64,7
> 85 2 0,0 0,0 50,0 0,0 0,0 0,0 0,0 0,0 0,0 50,0




Up to 1 368 2,2 5,7 0,0 0,0 3,8 1,1 40,2 5,2 10,6 72,6
1 - 4 416 1,9 9,6 0,2 0,0 8,2 2,6 22,8 3,8 11,1 66,1
5 - 17 115 4,3 17,4 1,7 0,0 1,7 2,6 10,4 1,7 11,3 54,8
18 - 49 305 1,0 19,0 2,0 0,0 1,0 1,0 1,6 0,7 7,5 36,1
50 - 64 53 0,0 18,9 7,5 0,0 1,9 0,0 0,0 1,9 5,7 39,6
65 - 74 11 0,0 18,2 9,1 0,0 0,0 0,0 9,1 0,0 9,1 45,5
75 - 84 22 4,5 18,2 4,5 0,0 9,1 0,0 4,5 0,0 0,0 45,5
> 85 1 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0 0,0
Total 1291 1,9 12,0 1,2 0,0 4,3 1,6 20,3 3,1 9,7 58,2
1 Virus abbreviations: B/Yamagata (B/Yam), B/Victoria (B/Vic), parainfluenza (PIV), adenovirus (AdV), respiratory syncytial virus (RSV), 
coronavirus (CoV), rhinovirus (RV). 
Note: The most affected age groups by influenza viruses marked in gray, affected by other respiratory viruses marked in green color.
Fig.1. Change of dominating influenza viruses by season and increase of RSV and rhinovirus activity in the season 2013-2014.
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corresponding IAPs. During the following weeks of 2013, 
the rate of the diagnosed influenza A(H1N1)pdm09 
cases increased rapidly. The number of patients, both 
children and adults, with isolated influenza A(H3N2) 
and B viruses, on the contrary began to increase in the 
second part of epidemic period. Influenza activity was 
higher in the epidemic of 2013 in comparison with 2014 
when influenza A(H1N1)pdm09 virus was isolated rarely 
and only weak growth of influenza A(H3N2) activity was 
observed. Decrease of influenza cases in both seasons 
was observed after week 17 and the investigation was 
stopped on the week 22, when the last single influenza 
cases were detected (Fig.2).
On the other hand, against the background of low 
influenza activity, RSV infection burden became very 
high for the period from week 5 to week 17 of 2014, 
especially among children. The proportion of influenza, 
RSV and rhinovirus among all hospitalized patients was 
39.6%, 6.7%, and 2.6% in IAP-2013, and 17.4%, 20.3% and 
9.7% in IAP-2014, respectively. 
Interestingly, in the period of high influenza 
activity (IAP-2013) the contribution of ARI agents was 
Fig. 2. Etiological monitoring of influenza among children (A) and adult (B) patients hospitalized for the period from week 3 to week 22, 
in the 2012- 2013 and 2013-2014 seasons.
A
B
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insignificant and vice versa; in the season with low 
influenza activity (IAP- 2014) the role of ARI agents as a 
cause for the patients’ hospitalization notably increased.
It should be noted that even in the season of low 
influenza activity, influenza viruses dominated among 
hospitalized adults; at the same time, RSV and rhinovirus, 
however, prevailed among children. The total percent of 
ARI reached 62.8%, 52.2%, and 27.8% among the children 
of 0 to 2, 3 to 6, and 7 to 14 years old, respectively 
(Table  2). It is interesting that IAP coincided with RSV 
increased activity in 2014 although such a clear tendency 
was not observed in 2013.
During both seasons, the number of male hospitalized 
patients with ILI was higher than the number of 
females (15.9% and 12.9% in IAP-2013 and IAP-2014 
IAP, respectively), but female patients had more often 
influenza A and B viruses, especially infant girls younger 
than 1 year old and 1 to 4 years old, than boys of these 
age groups. 
Etiology of SARI among the patients hospitalized 
in ICU
In total, 11 patients (0.65% of the total number) and 
18 patients (1.4% of the total number) were admitted 
to ICU in IAP-2013 and IAP-2014, respectively. Most 
of ICU patients (5 in 2013 and 15 in 2014) were young 
children younger than 3 months old while the others 
(with one exception) were adults. Virus etiology of SARI 
among young children placed in ICU was associated with 
RSV in 7 cases (35.0% of the total number of cases for 
both seasons) and with rhinovirus in 3 cases (15.0%), 
correspondingly. Etiology of SARI among adults placed 
in ICU was associated with the dominating influenza 
viruses, namely two cases with influenza A(H1N1)pdm09 
and one case with influenza B (Yamagata lineage) in IAP-
2013 and only one case with influenza A(H3N2) in IAP-
2014. The main reasons for ICU admission of patients 
were pneumonia, respiratory failure, hyperthermia, or 
heart failure.
Clinical diagnosis and symptoms of laboratory 
confirmed influenza and other respiratory viruses 
among the hospitalized patients
Analysis of the admission data for hospitalized patients 
was conducted first for IAP-2014. We revealed that the 
most often diagnosis at admission was “Acute upper 
respiratory infection” (AURI), namely 27.2%, 21.9%, 
and 40.9% of total cases for the International codes 
J06, J06.8 and J06.9, respectively. Several patients were 
hospitalized with acute tonsillitis (5.8%) and pneumonia 
(3.1%). Other diagnoses were registered sporadically. 
 Influenza viruses of A(H1N1)pdm09 subtype in 
IAP-2013 or A(H3N2) in 2014, RSV, and rhinoviruses 
dominated as etiological agents independently from 
primary clinical diagnosis. The exceptions were the 
acute tonsillitis cases where adenovirus and rhinovirus 
were detected as the causative pathogen in addition to 
influenza. It was only in one pneumonia case that the 
causative agent was proved to be metapneumovirus.
The main diagnoses at admission for the children 0 to 
2 years old were AURI and stenosis of the larynx; for the 
group of children 3 to 6 years old - AURI, bronchitis and 
pneumonia and for the group 7 to 17 years old - AURI, 
bronchitis and otitis with sinusitis. A similar pattern of 
clinical diagnoses (AURI, bronchitis and pneumonia) 
with the addition of tonsillitis was observed among 
adult patients 18 to 64 years old, although among the 
65 year old patients, pneumonia and bronchitis with 
cardiovascular disease (CVD) and chronic obstructive 
pulmonary disease (COPD), as comorbidities, were the 
main reasons for hospitalization.
The most common symptoms for influenza among 
the young children included fever, malaise, cough, 
and rarely dyspnea; in groups of children 3 to 6 and 
7 to 17  years old and in adults these were sore throat, 
headache, and sometimes myalgia, while dyspnea was 
observed extremely rare. It should be noted that most 
of these clinical symptoms were revealed by both the 
patients with influenza and the patients with negative 
PCR-confirmed diagnose for influenza and, therefore, 
cannot be considered as a hallmark of influenza. 
Concomitant chronic conditions 
Heart disease (HD). During IAP-2013 and IAP-2014, 
HD was diagnosed in 88 and 64 patients, respectively, 
and in both periods the percent of HD cases was the 
highest among the patients 50 years and older (86.6% 
and 76.6%, respectively). During both periods, the 
influenza A virus predominantly affected this age group 
(50 years and older), while influenza B virus was detected 
more often in groups of younger patients. The average 
percent of influenza cases among patients with HD was 
higher in IAP-2013, when influenza A(H1N1)pdm09 
dominated, in comparison to IAP-2014, when influenza 
A(H3N2) prevailed, (60.2% and 25.0%, respectively). On 
the contrary, the contribution of the other ARI agents 
increased in IAP-2014 when compared to IAP-2013 from 
1.1% to 18.8% with the predominance of rhinovirus (7.8%) 
and RSV (6.3%) and rear occurrence of parainfluenza 
(3.1%) and coronavirus (1.6%).
COPD. COPD was diagnosed mostly among the 
patients 50 years old and older. In total, 58.8% and 35.3% 
COPD complications among the patients hospitalized 
with ILI were associated with influenza A in IAP-2013 
and IAP-2014, respectively. Influenza B caused this 
complication only in IAP-2014 (in 5.9% cases). COPD 
associated with non-influenza respiratory viruses 
(mostly rhinovirus and parainfluenza) was detected only 
in 2014 in 17.6% of patients. 
Asthma. Asthma was diagnosed among 1.0% and 
1.6% of all the hospitalized patients with ILI in 2013 and 
2014, respectively. In IAP-2013, asthma was associated 
with influenza A in 35.3% of the cases (mostly with 
A(H1N1)pdm09 virus) and in 11.8% cases with influenza 
B viruses (equally distributed between the Yamagata 
and Victoria lineages). Rhinovirus was isolated in 11.8% 
and adenovirus in 5.9% of asthma cases. In IAP-2014, 
influenza A and B viruses were detected rarely: in 14.3% 
and 4.8%, respectively. On the other hand, the activity of 
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other respiratory viruses increased, namely rhinovirus, 
RSV and coronavirus were dominating (14.3%, 9.5%, and 
4.8%, respectively).
Diabetes. Diabetes was diagnosed as a complication 
in 23 (1.3%) hILI cases in IAP-2013 and in 12 (0.9%) cases 
in IAP-2014. Influenza A and B viruses were isolated from 
those patients who had this complication, in 39.1% and 
17.4% (only Yamagata lineage), respectively, in IAP-2013 
and in 33.3% (mostly H3N2) in IAP-2014. Parainfluenza 
virus (in 8.3% cases) and no influenza B virus were 
isolated from patients with diabetes in IAP-2014.
Immunodeficiency (ID). ID as a complication from 
ILI was diagnosed among 9 (0.7%) patients only in IAP-
2014. 22% of ID cases were caused by influenza A(H3N2) 
infection and 22.2% by rhinovirus infection. No other 
respiratory agents were isolated among patients with ID 
complication.
Genetic and antigenic characteristics of influenza 
A and B viruses isolated in St. Petersburg
It is well known that influenza vaccine efficacy depends 
on the antigenic matching of the vaccine strains to the 
circulating viruses. This fact determines the need to 
monitor the drift of influenza virus in order to adjust 
the vaccine composition. We obtained and antigenically 
characterized 230 influenza viruses in total, including 
168 influenza A viruses: 135 strains of influenza A(H3N2) 
and 33 strains of influenza A(H1N1)pdm09, and 62 
influenza B viruses: 45 strains of Yamagata and 17 strains 
of Victoria lineage. All of these viruses were isolated 
from specimens collected in St. Petersburg during IAP-
2013 and IAP-2014. Besides HA and NA, M genes of 45 
influenza A and B strains, isolated from these specimens, 
were sequenced and analyzed.
A(H3N2) viruses. During both epidemic seasons, 
isolated influenza A(H3N2) viruses revealed decreased 
titers in HI with ferret and rat antisera to the A/
Victoria/361/2011 strain, but did not differ from the 
reference strain A/Texas/50/2012 included in vaccine 
composition in Russia.
According to HA genetic analysis all sequenced 
influenza A(H3N2) viruses belonged to the A/
Victoria/361/2011 clade and had amino acid 
substitutions S45N, T48I, A198S, V223I, and N312S in 
HA1 and N158D in HA2 subunits specific for the genetic 
group 3С. Substitutions of 3C.3 subgroup Q33R, N278K, 
N145S, T128A (leading to the loss of potential site of 
glycosylation) and R142G were also detected (similar 
to reference strain A/Samara/73/2013) (Fig. 3). Only 
one strain, isolated in the end of IAP-2014, belonged to 
subgroups 3C.2a with substitutions L3I, N144S (loss of 
potential glycosylation site), F159Y, K160T (appearance 
of potential glycosylation site), V186G, N225D, Q311H, 
and D160N.
Thus, most of the analyzed influenza A(H3N2) viruses 
were drift-variants of А/Victoria/361/2011 virus by their 
genetic properties and were closely antigenically related 
to influenza virus A/Texas/50/2012.
A(H1N1)pdm09 viruses. Most of the 
analyzed influenza A(H1N1)pdm09 viruses were 
A/California/07/2009-like and reacted well with the 
antisera to influenza А/South Carolina/20/2010, 
A/Christchurch/16/2010, А/Нong Kong/5659/2012 and 
to domestic reference-strains А/ St. Petersburg /27/2011 
and А/ St. Petersburg/26/2013. These data illustrate a very 
slow antigenic drift of influenza A(H1N1)pdm09 virus 
despite the gradual accumulation of point mutations in 
HA gene.
All the A(H1N1)pdm09 viruses, sequenced from 
original clinical samples obtained in 2013-2014, 
belonged to group 6 (A/St.Petersburg/27/2011-like) and 
were attributed to the separate subgroup 6B (A/South 
Africa/3626/2013) bearing the amino acid substitutions 
K163Q (Sa), K283E, and A256T in HA1 and E172K in HA2 
subunits. The HA sequence of virus in the original clinical 
sample A/St.Petersburg/RII469S/2014 also contained 
substitutions V167I, A181S in HA2. (Fig. 4).
Influenza B viruses. The co-circulation of 
influenza B viruses of two lineages was observed in St. 
Petersburg in 2013-IAP with the domination of viruses 
from the Yamagata lineage. Influenza B viruses have 
not undergone substantial antigenic change. Thus, 
Victoria viruses retained the antigenic relationship to 
B/Brisbane/60/2008 reference strain recommended 
for the composition of influenza vaccine in 2009-2012 
seasons. Viruses of the Yamagata lineage of the 2012-2013 
season were antigenically similar to the reference strains 
B/Bangladesh/3333/2007 and B/Wisconsin/1/2010, but 
some isolates had reduced titers in HI test with antisera 
to influenza B/Wisconsin/1/2010 strain. In the IAP-
2014, only influenza B viruses of the Yamagata lineage 
were isolated in St. Petersburg. These strains differed 
significantly in the HI test from the vaccine strain 
В/Massachusetts/2/2012 with an eightfold reduction of 
antibody titer to this virus. According to genetic analysis, 
HA of influenza B viruses of Yamagata lineage isolated in 
IAP- 2013 belong to clade 2 (B/Brisbane/03/2007-like) and 
have amino acid substitutions R48K (in antigenic site BC), 
I150S (in BA site), Y165N (in BB2 site), and T181A (in BD 
site) (Fig. 5). Influenza strains isolated in 2014 as well as 
viruses isolated from the swabs of hospitalized patients, 
belonged to clade 3 (B/Wisconsin/01/2010-like) and had 
10 amino acid substitutions. Four of these substitutions 
were in the antigenic sites: N116K (BC), S150I (BA), 
N165Y (BB2), A181T (BD). These substitutions indicated 
the reappearance in the circulation of viruses isolated 
earlier (in 2011-2012 season) that proves the necessity 
of the replacement of the Yamagata lineage influenza 
B  virus in vaccine composition for the forthcoming 
season, at least for Russia.
No specific distinctions related to clinical signs and 
severity of influenza disease were revealed in the HA 
structure of all the studied viruses. Mutations related 
to the neuraminidase inhibitors’ resistance were not 
detected in the studied viruses, but all the studied 
influenza A viruses were resistant to adamantanes 
according to their M gene structure.
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Fig. 3. HA phylogenetic tree of influenza A(H3N2) viruses isolated in the 2012-2013 and 2013-2014 seasons from 
hospitalized patients with ILI symptoms. Vaccine strains are shown in green (actual season) or blue (previous season). 
Reference viruses are shown in dark blue. Viruses sequenced in the Research Institute of Influenza are shown in red.
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Fig. 4. HA phylogenetic tree of influenza A(H1N1)pdm 09 viruses isolated in the 2012-2013 and 2013-2014 seasons from hospitalized 
patients with ILI symptoms. Reference viruses are shown in green. Viruses sequenced in the Research Institute of Influenza are shown in 
red. ¿ – vaccine viruses.
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Fig. 5. HA phylogenetic tree of influenza B viruses of the Yamagata lineage isolated in the 2012-2013 and 2013-2014 seasons from 
hospitalized patients with ILI symptoms. Reference viruses are shown in dark blue. ¿ – vaccine virus.
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DISCUSSION 
This investigation contributed to the creation of the 
platform for international state-private partnership in 
order to find solutions for the clinical and epidemiological 
problems of influenza infection. The rate of influenza 
infection in comparison with other ARI viruses among 
hospitalized children and adults was investigated. Using 
a RT-PCR diagnosis, we demonstrated that influenza 
viruses were the dominant causative agents of hILI 
among the adult patients during the 2013 and 2014 
influenza seasons. In IAP-2013, influenza A(H1N1)pdm09 
and B (Yamagata lineage) viruses prevailed as the 
etiological agents of hILI cases. Illnesses, caused by 
influenza viruses of A(H3N2) subtype and B (Victoria 
lineage), that led to patient hospitalization, occurred 
much more rarely in both periods. Conversely, in IAP-2014 
cases involving A(H3N2) influenza viruses were observed 
predominantly while the activity of influenza B viruses 
was low and only viruses belonging to Yamagata lineage 
were isolated in this period. These data are consistent 
with the results obtained in other cities of Russia and 
in the most of other European countries. The rate of 
influenza virus infection among children was lower in 
comparison to adults. In both seasons, the important role 
of RSV and rhinovirus was determined among the groups 
of hospitalized with ILI young patients, especially in the 
groups of children younger than 1 year old and 1 to 4 years 
old. The number of cases with isolated parainfluenza, 
adenovirus, metapneumovirus and coronavirus was 
lower and was minimal for bocavirus.
We showed the important role of influenza viruses 
in the development of complications among the hILI 
patients - adults (pneumonia and bronchitis) as well 
as among children (stenosis of larynx, pneumonia). 
According to the clinical data, chronic comorbidities 
such as CVD, COPD, diabetes, and immunodeficiency 
were developed mainly among adult patients 50 years 
old and older.
Most of the ICU patients (69.0%) were children 
younger than 3 months old during both epidemic 
seasons. The etiology of ILI for children, admitted to 
ICU, was associated with RSV and rhinovirus. Among the 
adult ICU patients, only influenza viruses were detected.
The most common diagnosis at the time of patients’ 
admission to the hospital was acute upper respiratory 
infection; in some cases, acute tonsillitis and pneumonia 
were diagnosed. Influenza, RSV, and rhinoviruses 
dominated as the etiological agents of hILI independently 
from clinical diagnosis. An exception occurred in one case 
with a diagnosis of acute tonsillitis in which adenovirus 
and rhinovirus were detected in addition to influenza. 
According to the results of antigenic and genetic 
analysis, most of the circulated influenza A viruses 
matched the vaccine strains recommended by the 
WHO for the 2012-2013 and 2013-2014 seasons. A 
very slow antigenic drift of influenza A(H1N1)pdm09 
virus was noticed despite the gradual accumulation of 
point mutations in HA gene. Influenza A(H3N2) strains 
antigenically were similar to A/Texas/50/2012 influenza 
virus and according to phylogenetic analysis belonged to 
the clade of A/Victoria/361/2011 (subgroup 3C.3). Most of 
analyzed strains had two-three amino acid substitutions 
in HA antigenic sites. At the same time, most of 
isolated in IAP-2014 influenza B viruses of Yamagata 
lineage differed antigenically from the vaccine strain 
В/Massachusetts/2/2012 and were divided to 2 groups. 
The first group was similar to clade 2 (B/Brisbane/03/2007-
like) viruses, while the second group - to the viruses of 
clade 3 (B/Wisconsin/01/2010-like). 
The obtained results emphasize the necessity of 
expanding the existing influenza surveillance system 
and ARI in Russia with the inclusion of profound hospital 
surveillance based on laboratory confirmed etiology. This 
will help to strengthen the influenza surveillance system 
in order to provide a forewarning of influenza outbreaks 
and the emergence of novel influenza viruses. 
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